search
Back to results

Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly (ImpresU-WP2)

Primary Purpose

Urinary Tract Infections

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
antibiotic stewardship intervention
Sponsored by
Cees Hertogh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Urinary Tract Infections focused on measuring cluster randomized trial, antibiotic stewardship, frail elderly

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • physical and/or mental disabilities and ADL dependency requiring residential care or nursing home care
  • attended by general practitioners
  • not on continuous prophylactic antibiotic use

Exclusion Criteria:

  • in hospice-care
  • very limited life expectancy (≤1 month)
  • no longer wish to participate
  • start continuous antibiotic (prophylaxis)
  • die or move away from the residential care home / nursing home

If patients are excluded within 2 months after inclusion, they will be taken out of the study. In other words: patients need to be included for at least 2 months to contribute data to the study.

Sites / Locations

  • University Medical Center Utrecht
  • University of Oslo
  • Medical University of Lodz
  • Research and Development Primary Health Care, Region Västra Götaland

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

intervention

control

Arm Description

The antibiotic stewardship intervention will encourage to prescribe according to the latest relevant UTI guidelines which promote more restrictive use of antibiotics in case of non-specific symptoms.

Usual care

Outcomes

Primary Outcome Measures

UTI prescriptions
Number of prescriptions of antibiotics for suspected urinary tract infections expressed per patient-year

Secondary Outcome Measures

Incorrect UTI prescriptions
Number of incorrect prescriptions of antibiotics for suspected UTI expressed per patient-year
UTI suspicions
Incidence of suspected UTI expressed per patient-year
Complications
Incidence of complications: delirium, pyelonephritis, sepsis and renal failure within 21 days after each UTI suspicion
Hospital referral
Incidence of referral to a hospital within 21 days after each UTI suspicion
Hospital admission
Incidence of hospital admission within 21 days after each UTI suspicion
Mortality
Mortality
Mortality after UTI suspicion
Mortality within 21 days after each UTI suspicion
UTI prescriptions in office hours
Number of prescriptions of antibiotics for suspected UTI in office hours expressed per patient-year

Full Information

First Posted
May 26, 2019
Last Updated
May 23, 2022
Sponsor
Cees Hertogh
Collaborators
UMC Utrecht, Medical University of Lodz, University of Oslo, Vastra Gotaland Region, Göteborg University
search

1. Study Identification

Unique Protocol Identification Number
NCT03970356
Brief Title
Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly
Acronym
ImpresU-WP2
Official Title
The Improving Rational Prescribing for Urinary Tract Infections in Frail Elderly (ImpresU) Project - Work Package 2 (WP2): a Cluster Randomised Multifaceted Antibiotic Stewardship Intervention Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
September 1, 2019 (Actual)
Primary Completion Date
July 21, 2021 (Actual)
Study Completion Date
July 21, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Cees Hertogh
Collaborators
UMC Utrecht, Medical University of Lodz, University of Oslo, Vastra Gotaland Region, Göteborg University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether a tailored multifaceted antibiotic stewardship intervention reduces antibiotic use for urinary tract infections in residential care homes and nursing homes attended by general practitioners. This will be evaluated in a pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach.
Detailed Description
Rationale: Almost 60% of antibiotics in frail elderly is prescribed for alleged UTI. About half of the antibiotics for UTI in this population are prescribed for non-specific signs and symptoms; a substantial part of these prescriptions might not be necessary. Research question: Does a tailored multifaceted antibiotic stewardship intervention reduce antibiotic use for UTI in residential care homes and nursing homes attended by general practitioners (GPs)? Study design, setting and population: A pragmatic cluster randomised controlled trial using a modified community-based participatory action research approach. In the intervention group the latest UTI guidelines (which are standard care) are actively implemented at the level of the GP/caregivers. Residents ≥ 70 year with ADL dependency from 34 care homes + attending GP practices will participate in Norway, Sweden, Poland and the Netherlands. Methods: The study has two measurement periods; a baseline period (5 months) and a follow-up period (7 months). In between the antibiotic stewardship intervention will be tailored and implemented in intervention practices. GPs will prospectively register suspected UTIs on standardized registration forms and (study) nurses/assistants will follow-up patients at day 7 and day 21 for each UTI. Patients will be enrolled prior to the start of the study. June-August 2019: patient are recruited, informed consent is obtained, baseline characteristics of patients are recorded Sept 2019: study starts (from this moment onwards, the outcomes are being assessed). Data analysis: The primary analysis will be to assess the number of prescriptions of antibiotics for suspected UTI in the follow-up period, correcting for the baseline period and controlled for pre-specified confounders, using a generalized linear mixed model for Poisson distributions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Urinary Tract Infections
Keywords
cluster randomized trial, antibiotic stewardship, frail elderly

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The investigators will perform a pragmatic cluster randomised controlled trial (cRCT). The targeted population consists of frail elderly residents of residential care homes and nursing homes attended by general practitioners. The clusters (care home + general practitioners) are assigned to intervention- or control group. In the intervention group, an antibiotic stewardship intervention is actively implemented at the level of the general practitioners and caregivers in the homes. The study has two measurement periods; a baseline period (5 months) and a follow-up period (7 months). In between there is an implementation period in which the intervention (i.e. active implementation) is started in the intervention homes [no measurements are taken].
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1146 (Actual)

8. Arms, Groups, and Interventions

Arm Title
intervention
Arm Type
Experimental
Arm Description
The antibiotic stewardship intervention will encourage to prescribe according to the latest relevant UTI guidelines which promote more restrictive use of antibiotics in case of non-specific symptoms.
Arm Title
control
Arm Type
No Intervention
Arm Description
Usual care
Intervention Type
Other
Intervention Name(s)
antibiotic stewardship intervention
Intervention Description
The intervention is multifaceted, consisting of the implementation of an algorithm for restrictive use of antibiotics as proposed in recent guidelines (Verenso, Dutch guideline), tailored in close collaboration with local stakeholders to the specific implementation setting, by means of a modified participatory-action research (PAR) approach. To support the process of intervention-tailoring and -implementation, a toolbox comprising of materials, aids and actions is developed to be used at the discretion of the local stakeholders to support implementation of the algorithm.The algorithm is congruent with the Swedish and Norwegian guidelines, which also promote more restrictive use of antibiotics in case of non-specific symptoms, even though the algorithm is more detailed.
Primary Outcome Measure Information:
Title
UTI prescriptions
Description
Number of prescriptions of antibiotics for suspected urinary tract infections expressed per patient-year
Time Frame
Assessed during the 7-month follow-up period
Secondary Outcome Measure Information:
Title
Incorrect UTI prescriptions
Description
Number of incorrect prescriptions of antibiotics for suspected UTI expressed per patient-year
Time Frame
Assessed during the 7-month follow-up period
Title
UTI suspicions
Description
Incidence of suspected UTI expressed per patient-year
Time Frame
Assessed during the 7-month follow-up period
Title
Complications
Description
Incidence of complications: delirium, pyelonephritis, sepsis and renal failure within 21 days after each UTI suspicion
Time Frame
Assessed during the 7-month follow-up period
Title
Hospital referral
Description
Incidence of referral to a hospital within 21 days after each UTI suspicion
Time Frame
Assessed during the 7-month follow-up period
Title
Hospital admission
Description
Incidence of hospital admission within 21 days after each UTI suspicion
Time Frame
Assessed during the 7-month follow-up period
Title
Mortality
Description
Mortality
Time Frame
Assessed during the 7-month follow-up period
Title
Mortality after UTI suspicion
Description
Mortality within 21 days after each UTI suspicion
Time Frame
Assessed during the 7-month follow-up period
Title
UTI prescriptions in office hours
Description
Number of prescriptions of antibiotics for suspected UTI in office hours expressed per patient-year
Time Frame
Assessed during the 7-month follow-up period

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: physical and/or mental disabilities and ADL dependency requiring residential care or nursing home care attended by general practitioners not on continuous prophylactic antibiotic use Exclusion Criteria: in hospice-care very limited life expectancy (≤1 month) no longer wish to participate start continuous antibiotic (prophylaxis) die or move away from the residential care home / nursing home If patients are excluded within 2 months after inclusion, they will be taken out of the study. In other words: patients need to be included for at least 2 months to contribute data to the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cees MP Hertogh, prof. dr.
Organizational Affiliation
Amsterdam UMC, location VUmc
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Theo JM Verheij, prof. dr.
Organizational Affiliation
UMC Utrecht
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Maciek Godycki-Cwirko, prof.dr.
Organizational Affiliation
Medical University of Lodz
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Morten Lindbæk, prof. dr.
Organizational Affiliation
University of Oslo
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Pär-Daniel Sundvall, MD PhD
Organizational Affiliation
Göteborg University
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Medical Center Utrecht
City
Utrecht
ZIP/Postal Code
3584 CG
Country
Netherlands
Facility Name
University of Oslo
City
Oslo
ZIP/Postal Code
1130
Country
Norway
Facility Name
Medical University of Lodz
City
Łódź
ZIP/Postal Code
90-153
Country
Poland
Facility Name
Research and Development Primary Health Care, Region Västra Götaland
City
Borås
ZIP/Postal Code
SE-503 38
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34620666
Citation
Hartman EAR, Groen WG, Heltveit-Olsen SR, Lindbaek M, Hoye S, Sundvall PD, Gunnarsson R, Skoglund I, Snaebjornsson Arnljots E, Godycki-Cwirko M, Kowalczyk A, Platteel TN, Zuithoff NPA, Monnier AA, Verheij TJM, Hertogh CMPM, van de Pol AC. Multifaceted antibiotic stewardship intervention using a participatory-action-research approach to improve antibiotic prescribing for urinary tract infections in frail elderly (ImpresU): study protocol for a European qualitative study followed by a pragmatic cluster randomised controlled trial. BMJ Open. 2021 Oct 7;11(10):e052552. doi: 10.1136/bmjopen-2021-052552.
Results Reference
derived

Learn more about this trial

Improving Antibiotic Prescribing for Urinary Tract Infections in Frail Elderly

We'll reach out to this number within 24 hrs